| abstract |
The present invention relates to a method for inhibiting an increase in matrix metalloproteinase (MMP) activity or reducing MMP activity in a subject in need by administering to the subject a therapeutically effective amount of a selective aldosterone blocker. More particularly, the present invention relates to reducing or inhibiting an increase in MMP activity, including administration of eplerenone or a derivative thereof. |